Life Sciences Collaborative – NJ Meeting Highlights Innovation in mRNA Therapeutics and Cancer Treatment
LSC NJ meeting featured Anvesana and Guidant BioTherapeutics discussing mRNA therapies, oncology innovation, fundraising, and the future of biotechnology in New Jersey.
Key Insights from the JP Morgan 2026 Healthcare Conference | LSC NJ
At the February 12, 2026 meeting of the Life Science Collaborative of New Jersey (LSC NJ), Peter Jaslow of Ballard Spahr LLP and John Pennett of EisnerAmper led a strategic discussion on the most important takeaways from the JP Morgan 2026 Healthcare Conference. The session examined biotech financing trends, healthcare capital markets activity, life sciences […]